Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.
SpermCheck in August gained additional retail distribution for its SpermCheck Fertility, an FDA-approved at-home screening test that determines with 98% accuracy whether a man has a normal or low sperm count. Infertility affects nearly 7 million U.S. couples every year.
The American Heart Association’s journal Hypertension this summer plugged home blood-pressure monitoring kits, noting that the self-care diagnostics can save insurance companies money by improving healthcare quality and reducing healthcare costs — both buzz words in the changing healthcare paradigm that places a greater emphasis on preventive health care.
That’s what has always excited CVS/pharmacy president Helena Foulkes about the business ever since she took her first job in retail, some 22 years ago, at the only retail company she has ever worked for.